Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
GHK-Cu, BPC-157, TB-500, and KPV are four individual peptides of this stack, each having well-studied, unique mechanisms of action
Absolute contraindications: Known allergy to either peptide or its components Active cancer (insufficient safety data) Pregnancy or breastfeeding (insufficient safety data) Severe immunocompromise (theoretical concern) Relative contraindications (require careful consideration): History of cancer (consult a medical advisor) Major cardiac disease (monitor closely) Severe liver or kidney disease (may affect clearance) Active infections (wait until resolved) Bleeding disorders (monitor injection sites carefully) Special populations: Elderly subjects: usually well tolerated, no dose adjustment needed Subjects with multiple conditions: enhanced monitoring recommended Those on multiple medications: review for possible interactions Drug Interactions The peptides have minimal documented drug interactions
Many people turn to peptide therapy because theyre seeking a medically guided way to address concerns that havent responded to other treatments
Potential signs and symptoms include (Schett 2011
This pack size is ideal for medium scale experiments, testing new procedures, and regular laboratory applications without having excess product that might go to waste
